SNY
Sanofi · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -7.7% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 517.20K | $21.14M | n/a | n/a |
| Q2 2026 | 111 | +6 | 144.61M | $6.22B | +8 | −2 |
| Q1 2026 | 107 | -7 | 161.36M | $7.80B | +3 | −10 |
| Q4 2025 | 113 | 0 | 171.90M | $8.37B | n/a | n/a |
| Q3 2025 | 17 | 0 | 119.31M | $5.63B | +1 | −1 |
| Q2 2025 | 14 | -1 | 113.96M | $5.51B | n/a | −1 |
| Q1 2025 | 13 | -1 | 114.44M | $6.35B | +1 | −2 |
| Q4 2024 | 14 | 0 | 106.76M | $5.15B | n/a | n/a |
| Q3 2024 | 13 | 0 | 105.96M | $6.11B | +1 | −1 |
| Q2 2024 | 13 | n/a | 103.00M | $5.00B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 68.93M | -3.9% | $3.25B | 1.8% | ▼ Trim | 6 | SEC ↗ |
| 2 | Fisher Asset Management ✦ | 12.58M | -4.2% | $593.72M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 7.56M | n/a | $356.92M | 0.0% | n/c | 1 | SEC ↗ ×11 |
| 4 | T. Rowe Price ✦ | 5.87M | +6.3% | $277.23M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | BlackRock ✦ (passief) | 5.58M | +2.0% | $263.32M | 0.0% | ▲ Add | 2 | SEC ↗ ×9 |
| 6 | JPMorgan Chase ✦ | 5.31M | n/a | $250.67M | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 7 | Wellington Management ✦ | 4.12M | -4.8% | $194.64M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 8 | Fidelity (FMR) ✦ | 2.97M | -17.5% | $140.36M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 9 | Goldman Sachs Group ✦ | 2.48M | n/a | $117.02M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | Millennium Management ✦ | 1.43M | +1151.8% | $67.68M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 11 | PRIMECAP Management ✦ | 986.47K | -13.1% | $46.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 771.44K | +253.3% | $36.41M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | Point72 Asset Management ✦ | 369.33K | Nieuw | $17.43M | 0.0% | New | 1 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passief) | 232.50K | -0.9% | $10.97M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 66.32K | -8.8% | $3.13M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 16 | State Street Global Advisors ✦ (passief) | 24.28K | 0.0% | $1.15M | 0.0% | Held | 4 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 17.51K | -3.6% | $826,283 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Point72 Asset Management | $17.43M | 0.0% |
Verlaten
| Capital World Investors | $403.59M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 734 houders, 204.41M aandelen, $9.56B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.